Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

NCT03372850 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HIP1601
DRUG: HGP1705

Sponsor

Hanmi Pharmaceutical Company Limited